Literature DB >> 3999069

Uterine rupture in Nigeria.

T Elkins, E Onwuka, T Stovall, M Hagood, D Osborn.   

Abstract

Uterine rupture in the developing world remains a significant problem. We treated 45 such cases. The predisposing factors included cephalopelvic disproportion (62%), grand multiparity (33%), previous cesarean section (24%), placental pathology (15%) and abnormal presentation (20%). The factors associated with maternal death included sepsis (71%), macerated stillborn infant (60%), vulvar edema (50%), hand presentation (50%), prolonged labor (42%) and hysterectomy (37.5%). Hemodynamic resuscitation and prompt surgical intervention remain the mainstays of therapy.

Entities:  

Keywords:  Africa; Africa South Of The Sahara; Biology; Cultural Background; Delivery Of Health Care; Demographic Factors; Developing Countries; Diseases; English Speaking Africa; Genital Effects, Female; Genitalia; Genitalia, Female; Gynecologic Surgery; Health; Health Facilities; Health Services; Hospitals; Hysterectomy; Incidence; Indigenous Health Services; Maternal Mortality; Medicine, Traditional; Mortality; Nigeria; Obstetrical Surgery; Perforations; Physiology; Population; Population Characteristics; Population Dynamics; Pregnancy Complications; Prenatal Care; Research Report; Rural Health Services; Rural Population; Signs And Symptoms; Surgery; Treatment; Tubal Ligation; Tubal Occlusion; Urogenital Surgery; Urogenital System; Uterine Effects; Uterine Perforation; Uterus; Western Africa

Mesh:

Year:  1985        PMID: 3999069

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  2 in total

1.  Ruptured uterus in pregnancy: a Canadian hospital's experience.

Authors:  D M Fedorkow; C A Nimrod; P J Taylor
Journal:  CMAJ       Date:  1987-07-01       Impact factor: 8.262

2.  Erect lateral pelvimetry and the outcome of labor in Lagos.

Authors:  O K Ogedengbe; O Okikiolu; R I Macrae; O F Giwa-Osagie
Journal:  J Natl Med Assoc       Date:  1993-01       Impact factor: 1.798

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.